RIPE-KG · Version 1.1.0 · Resource
ripekg:work/RIPEW341DD8F8C208326C
https://w3id.org/ripe/ripe-kg/work/RIPEW341DD8F8C208326C
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW341DD8F8C208326CKetamine for treatment-resistant depression: when and where is it safe |
ripekg:work/RIPEW341DD8F8C208326CKetamine for treatment-resistant depression: when and where is it safe |
dcterms:title |
Ketamine for treatment-resistant depression: when and where is it safe |
ripekg:work/RIPEW341DD8F8C208326CKetamine for treatment-resistant depression: when and where is it safe |
rdf:type |
node1 |
ripekg:work/RIPEW341DD8F8C208326CKetamine for treatment-resistant depression: when and where is it safe |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/RIPEW341DD8F8C208326CKetamine for treatment-resistant depression: when and where is it safe |
rdf:type |
rdfs:Resource |
ripekg:work/RIPEW341DD8F8C208326CKetamine for treatment-resistant depression: when and where is it safe |
rdf:type |
owl:Thing |
ripekg:work/RIPEW341DD8F8C208326CKetamine for treatment-resistant depression: when and where is it safe |
rdf:type |
prov:Entity |
ripekg:work/RIPEW341DD8F8C208326CKetamine for treatment-resistant depression: when and where is it safe |
rdf:type |
ripe:WorkWork |